For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Intuitive Surgical (ISRG - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Intuitive Surgical is a member of our Medical group, which includes 764 different companies and currently sits at #10 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. ISRG is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for ISRG's full-year earnings has moved 11.40% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the most recent data, ISRG has returned 28.35% so far this year. Meanwhile, stocks in the Medical group have lost about 2.08% on average. As we can see, Intuitive Surgical is performing better than its sector in the calendar year.
Looking more specifically, ISRG belongs to the Medical - Instruments industry, which includes 88 individual stocks and currently sits at #107 in the Zacks Industry Rank. On average, stocks in this group have lost 6.58% this year, meaning that ISRG is performing better in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track ISRG. The stock will be looking to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Intuitive Surgical (ISRG - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Intuitive Surgical is a member of our Medical group, which includes 764 different companies and currently sits at #10 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. ISRG is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for ISRG's full-year earnings has moved 11.40% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the most recent data, ISRG has returned 28.35% so far this year. Meanwhile, stocks in the Medical group have lost about 2.08% on average. As we can see, Intuitive Surgical is performing better than its sector in the calendar year.
Looking more specifically, ISRG belongs to the Medical - Instruments industry, which includes 88 individual stocks and currently sits at #107 in the Zacks Industry Rank. On average, stocks in this group have lost 6.58% this year, meaning that ISRG is performing better in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track ISRG. The stock will be looking to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ISRG - FREE